about
The Alzheimer's amyloid-degrading peptidase, neprilysin: can we control it?Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disordersBiomarkers in amyloid-β immunotherapy trials in Alzheimer's disease.Design of Peptide Substrate for Sensitively and Specifically Detecting Two Aβ-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme.Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling.Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's diseaseReduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysinObesity, diabetes, and leptin resistance promote tau pathology in a mouse model of disease.Transgenerational latent early-life associated regulation unites environment and genetics across generationsPolyhydroxycurcuminoids but not curcumin upregulate neprilysin and can be applied to the prevention of Alzheimer's disease.Characterization of insulin degrading enzyme and other amyloid-β degrading proteases in human serum: a role in Alzheimer's disease?Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease.Amyloid beta accumulation in HIV-1-infected brain: The role of the blood brain barrierAre amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?Clearance of amyloid-beta in Alzheimer's disease: shifting the action site from center to periphery.Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease.Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).Neprilysin gene transfer: A promising therapeutic approach for Alzheimer's disease.Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.First-in-Class Composite Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Practice.Aβ-Degrading Proteases: Therapeutic Potential in Alzheimer Disease.Organotypic vibrosections from whole brain adult Alzheimer mice (overexpressing amyloid-precursor-protein with the Swedish-Dutch-Iowa mutations) as a model to study clearance of beta-amyloid plaques.The Role of Neprilysin Inhibitors in Cardiovascular Disease.A syringe-focused ultrasound device for simultaneous injection of DNA and gene transfer.Association Between Serum Amyloid-Beta and Renal Functions: Implications for Roles of Kidney in Amyloid-Beta Clearance.Sacubitril/Valsartan (LCZ696) in Heart Failure
P2860
Q21296650-27DCD0AF-FD68-4D5E-9FC1-D792459C83F3Q29615839-0A52E19C-83CC-4D80-BF62-50EEE7C09407Q30651551-A51EAB62-1E3D-44D1-83D2-3EC79C9DF13FQ35994771-687FAE91-3FA6-45FF-946E-28E614D042DCQ36052691-D9512074-4F9A-4D0A-A39E-F08EB94D0156Q36073671-4416DA7C-C1FD-4493-9FBA-D5B76E1C8155Q36319298-2F802EB6-92F5-468F-B3E7-F03863DE1D5EQ36471457-D34381D4-6A56-40B1-91CF-06FCFB6C3F6AQ36893180-21857F61-7295-4FDB-BFA9-D42D78830987Q37089706-250629DD-8B9A-4E92-A508-D86285ACA5C9Q37200279-8BE7B58C-931B-4CB4-91D8-BF4F19398A26Q37224550-D9E13A7C-BA96-4331-B47A-3FA299F822FDQ37243920-C76B95D0-106A-4082-9166-9A943564E4CCQ37961852-AE140751-A6C1-4FC3-BE54-40A492672B50Q38204711-3A93431A-1B81-4EAE-A536-BA58E04E58FCQ38256360-77157321-FFB8-43EE-83A0-61C08A4D2A1AQ38295848-CA01D0E4-D2AE-40BA-9A57-3A581186A44BQ38533753-F61DEB03-7981-4878-86E1-A4F2908000C7Q38601445-9842FB3D-0C6B-464F-B4A8-736B1F47AA04Q38781645-6DCC28E2-FB94-44B4-9749-E17AE9F3EDCEQ38878922-5FCE2746-80B3-402F-8D13-A35B4157C30CQ39440830-483ECAD5-F2BE-4C52-9CEC-1004E02C833FQ42700358-12EF9F50-AF99-4AE2-A8F3-90EF55F9C39EQ45875379-44FA8FEA-D849-437F-91DB-453E0BF12B9DQ48606515-56004D7E-7981-4E12-B849-995962C3AB39Q57396137-013F2566-1683-4E19-931E-2A8C997B5EC6
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Circulating neprilysin clears brain amyloid
@ast
Circulating neprilysin clears brain amyloid
@en
Circulating neprilysin clears brain amyloid
@nl
type
label
Circulating neprilysin clears brain amyloid
@ast
Circulating neprilysin clears brain amyloid
@en
Circulating neprilysin clears brain amyloid
@nl
prefLabel
Circulating neprilysin clears brain amyloid
@ast
Circulating neprilysin clears brain amyloid
@en
Circulating neprilysin clears brain amyloid
@nl
P2093
P2860
P1476
Circulating neprilysin clears brain amyloid
@en
P2093
Christa Studzinski
Louis B Hersh
M Paul Murphy
Ronald L Klein
Tina Beckett
Yinxing Liu
P2860
P304
P356
10.1016/J.MCN.2010.05.014
P577
2010-06-15T00:00:00Z